Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis

Rheumatology International

Volumn 19, Issue 1-2, 1999, Pages 39-46

  Distler, O ^a   Rinkes, B ^b   Hohenleutner, U ^b   Scholmerich J ^b   Landthaler, M ^b   Lang, B ^b   Gay, S ^a   Muller Ladner U ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

Chemokines; Keratinocytes; RANTES; Systemic sclerosis

Indexed keywords

CHEMOKINE; RANTES;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPIDERMIS; ESOPHAGUS BIOPSY; FEMALE; GASTROINTESTINAL BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SKIN BIOPSY; SYSTEMIC SCLEROSIS; UPPER GASTROINTESTINAL TRACT;

EID: 0033396567     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050098     Document Type: Article

References (44)

1. Gay S, Boulware DW, Gay RE (1994) Oncogenes, growth factors, and matrix in the pathogenesis of systemic sclerosis. Clin Dermatol 12:419-424
2. Piela-Smith TH, Korn JH (1994) Lymphocyte modulation of fibroblast function in systemic sclerosis. Clin Dermatol 12:369-378
3. Black CM, Welsh KI (1994) Genetics of scleroderma. Clin Dermatol 12:337-348
4. White B (1995) Immunologic aspects of scleroderma. Curr Opin Rheumatol 7:541-545
5. Sollberg S, Krieg T (1996) New aspects in scleroderma research. Int Arch Allergy Immunol 111:330-336
6. Furst DE, Clements PJ (1997) Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol [Suppl 48] 24:53-57
7. Gay S, Trabandt A, Moreland LW, Gay RE (1992) Growth factors, extracellular matrix, and oncogenes in scleroderma. Arthritis Rheum 35:304-310
8. Koch AE, Kronfeld-Harrington LB, Szekanecz Z, Cho MM, Haines GK, Harlow LA, Strieter RM, Kunkel SL, Massa MC, Barr WG, Jimenez SJ (1993) In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Pathobiology 61:239-246
9. Fagundus DM, Leroy EC (1994) Cytokines and systemic sclerosis. Clin Dermatol 12:407-417
10. Schroeder JM (1995) Cytokine networks in the skin. J Invest Dermatol 105:S20-S24
11. Gruschwitz MS, Albrecht M, Vieth G, Haustein U-F (1997) In situ expression and serum levels of tumor necrosis factor-α receptors in patients with early stages of systemic sclerosis. J Rheumatol 24:1936-1943
12. Bos JL, Kapsenberg ML (1993) The skin immune system: progress in cutaneous biology. Immunol Today 14:75-78
13. Williams IR, Kupper TS (1996) Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci 58:1485-1507
14. Luster AD (1998) Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445
15. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, Krensky AM (1988) A human T cell-specific molecule is a member of a new gene family. J Immunol 141:1018-1025
16. Snowden N, Hajeer A, Thomson W, Ollier B (1994) RANTES role in rheumatoid arthritis. Lancet 343:547-548
17. Yamada I, Izutani R, Chihara J, Yudate T, Matsukura M, Tezuka T (1996) RANTES mRNA expression in skin and colon of patients with atopic dermatitis. Int Arch Allergy Immunol [Suppl 1] 111:19-21
18. Noso N, Sticherling M, Bartels J, Mallet Al, Christophers E, Schroeder JM (1996) Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts. J Immunol 156:1946-1953
19. Satoh T, Chen QJ, Sasaki G, Yokozeki H, Katayama I, Nishioka K (1997) Cyclophosphamide-induced blood and tissue eosinophilia in contact sensitivity: mechanism of hapten-induced eosinophil recruitment into the skin. Eur J Immunol 27:85-91
20. Zweiman B, Kaplan AP, Tong L, Moskovitz AR (1997) Cytokine levels and inflammatory responses in developing latephase allergic reactions in the skin. J Allergy Clin Immunol 100:104-109
21. Volin MV, Shah MR, Tokuhira M, Haines GK, Woods JM, Koch AE (1998) RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 89:44-53
22. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980): preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
23. 35S-and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Histochemistry 98:217-228
24. Hosaka S, Akahoshi T, Wada C, Kondo H (1994) Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 97:451-457
25. Müller-Ladner U, Elices MJ, Kriegsmann JB, Strahl D, Gay RE, Firestein GS, Gay S (1997) Alternatively spliced CS-fibronectin isoform and its receptor VLA in rheumatoid arthritis synovium. J Rheumatol 24:1873-1880
26. Sticherling M, Kupper M, Koltrowitz F, Bornscheuer E, Kulke R, Klinger M, Wilhelm D, Kameyoshi Y, Christophers E, Schroeder JM (1995) Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 105:585-591
27. Marfaing-Kolka A, Devergne O, Gorgogne G, Portier A, Schall TJ, Galanaud P, Emilie D (1995) Regulation of the production of the RANTES chemokine by endothelial cells. J Immunol 154:1870-1878
28. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M (1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 15:853-857
29. Li J, Ireland GW, Farthing PM, Thornhill MH (1996) Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 106:661-666
30. 3 (tacalcitol). Br J Dermatol 138:63-70
31. Bergman N, Robichaud A, Krishnan VL, Roesems G, Robbins R, Jose PJ, Chung KF. (1996) Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology 87:599-603
32. Kahaleh MB (1991) Soluble immunologic products in scleroderma sera. Clin Immunol Immunopathol 58:139-144
33. Kawaguchi Y (1994) IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clin Exp Immunol 97:445-450
34. Meurer R, Van Riper G, Feeney W, Cunningham P, Hora D Jr, Springer MS, Macintyre DE, Rosen H (1993) Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein-1, human macrophage inflammatory protein -1α, or human interleukin-8. J Exp Med 178:1913-1921
35. Hershkowiz R, Marikovsky M, Gilat D, Lider O (1996) Keratinocyte-associated chemokines and enzymatically quiescent heparanase induce the binding of resting CD4+ T cells. J Invest Dermatol 106:243-248
36. Sjogren RW (1996) Gastrointestinal features of scleroderma. Curr Opin Rheumatol 8:569-575
37. Heufler C, Topar G, Trockenbacher B, Kampgen E, Romani N, Schuler G (1992) Cytokine gene expression in murine epidermal cell suspensions: interleukin-1 beta and macrophage inflammatory protein-1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med 176:1221-1226
38. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y (1998) EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 161:3096-3102
39. Nakamura K, Williams IR, Kupper TS (1995) Keratinocyte-derived monocyte chemoattractant protein-1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 105:635-643
40. Unemori EN, Amento EP, Bauer EA, Horuk R (1993) Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by CXC but not CC cytokines. J Biol Chem 268:1338-1342
41. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TNC, Salant DJ, Gutierrez-Ramos JC (1997) RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescentic formation and interstitial fibrosis. J Exp Med 185:1371-1380
42. Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM (1997) Cytokine concentrations in bronchoalveolar lavage fluids of patients with systemic sclerosis. Arthritis Rheum 40:743-751
43. Caiman HN, Giomo RC, Seibold JR (1991) Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". Arthritis Rheum 34:1495-1500
44. Freemont AJ, Hoyland J, Fielding P, Hodson N, Jayson MI (1992) Studies of the micro vascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy. Br J Dermatol 126:561-568